NEW YORK (GenomeWeb) – Curetis reported today a 12 percent drop in revenues for the first half of 2016 as it cut its net loss nearly in half year over year.

For the six months ended June 30, the Dutch and German molecular diagnostics firm tallied €654,682 ($741,296) in revenues compared to €742,035 in the first half of 2015.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.